Bank Pictet & Cie (Asia) LTD Biogen Inc. Transaction History

Bank Pictet & Cie (Asia) LTD

$1.57 Trillion
Q2 2024

A detailed history of Bank Pictet & Cie (Asia) LTD transactions in Biogen Inc. stock. As of the latest transaction made, Bank Pictet & Cie (Asia) LTD holds 1,444 shares of BIIB stock, worth $230,794. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,444

Previous 1,444 -0.0%

Holding current value

$230,794

Previous $311 Million 7.51%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$212.02 - $267.71 $771,540 - $974,196	-3,639 Reduced 71.59%	1,444 $311 Million
Q3 2023 Nov 02, 2023	BUY	$253.3 - $285.89 $318,904 - $359,935	1,259 Added 32.92%	5,083 $1.31 Billion
Q1 2023 May 05, 2023	SELL	$256.56 - $292.34 $10,518 - $11,985	-41 Reduced 1.06%	3,824 $1.06 Billion
Q4 2022 Feb 17, 2023	BUY	$252.44 - $306.72 $166,105 - $201,821	658 Added 20.52%	3,865 $1.07 Billion
Q3 2022 Nov 04, 2022	SELL	$194.69 - $268.46 $513,981 - $708,734	-2,640 Reduced 45.15%	3,207 $856 Million
Q2 2022 Aug 05, 2022	SELL	$187.54 - $223.02 $218,296 - $259,595	-1,164 Reduced 16.6%	5,847 $1.19 Million
Q1 2022 May 04, 2022	BUY	$193.77 - $244.14 $309,450 - $389,891	1,597 Added 29.5%	7,011 $1.48 Million
Q4 2021 Feb 04, 2022	BUY	$223.92 - $287.77 $346,180 - $444,892	1,546 Added 39.97%	5,414 $1.3 Million
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $78,105 - $101,857	276 Added 7.68%	3,868 $1.1 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $291,116 - $466,134	-1,124 Reduced 23.83%	3,592 $1.24 Million
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $383,132 - $448,861	1,577 Added 50.24%	4,716 $1.32 Million
Q3 2020 Nov 10, 2020	SELL	$264.77 - $305.71 $18,269 - $21,093	-69 Reduced 2.15%	3,139 $890,000
Q1 2020 Apr 30, 2020	SELL	$268.85 - $341.04 $168,837 - $214,173	-628 Reduced 16.37%	3,208 $1.02 Million
Q4 2019 Jan 31, 2020	SELL	$220.06 - $304.07 $3,520 - $4,865	-16 Reduced 0.42%	3,836 $1.14 Million
Q1 2019 May 01, 2019	BUY	$216.71 - $338.96 $314,229 - $491,491	1,450 Added 60.37%	3,852 $911,000
Q3 2018 Nov 07, 2018	SELL	$293.51 - $383.83 $183,737 - $240,277	-626 Reduced 20.67%	2,402 $849,000
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $779,770 - $929,323	3,028 New	3,028 $879,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Pictet & Cie (Asia) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bank Pictet & Cie (Asia) LTD with notifications on news.

Account

Bank Pictet & Cie (Asia) LTD Biogen Inc. Transaction History